
Developments in CAR T-Cell and Bispecific Therapies in R/R Multiple Myeloma
A panel of hematology/oncology experts considered ways to treat patients with relapsed/refractory (R/R) multiple myeloma during an Around the Practice program hosted by CancerNetwork. The panelists narrowed in on chimeric antigen receptor (CAR) …